SCHEMBL4018252

SCHEMBL4018252

CN(C[CH]c1ccc(OC(=O)c2cccc3ccccc23)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
GAA P10253 2/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 5/20 0.38
ALDH1A1 P00352 2/20 0.38
ADRB2 P07550 2/20 0.38
ADRB1 P08588 2/20 0.38
ADRB3 P13945 2/20 0.38
TDP1 Q9NUW8 2/20 0.37
NR1D1 P20393 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
BACE1 P56817 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4016939 0.82 KMT2A (0.52) KMT2AGAAMAPTALDH1A1TDP1
SCHEMBL4018256 0.82 KMT2A (0.43) KMT2AGAAPOLBMAPTALDH1A1
SCHEMBL2525569 0.80 BACE1 (0.47) KMT2AGAAPOLBMAPTALDH1A1
SCHEMBL28315299 0.75 ACHE (0.43) KMT2AGAAPOLBALDH1A1NR1D1
SCHEMBL27604498 0.72 KMT2A (0.43) KMT2AGAAPOLBALDH1A1ADRB2
SCHEMBL2529414 0.71 AURKA (0.38) MAPTALDH1A1ADRB2ADRB1ADRB3
SCHEMBL28151828 0.71 POLB (0.44) KMT2AGAAPOLBMAPTALDH1A1
SCHEMBL974720 0.71 NR4A1 (0.53) KMT2AGAAPOLBMAPTALDH1A1
SCHEMBL18020598 0.70 KMT2A (0.57) KMT2AGAAPOLBMAPTALDH1A1
SCHEMBL28813458 0.70 CACNA1B (0.59) KMT2AGAAPOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009092796-A1 SYNEPHRINE DERIVATIVES FOR THE TREATMENT OF CANCER UNIVERSITEIT GENT (BE) 2009-07-30 WO disclosed